MYC and cancer: Among different types of tumors, genetic alterations in PI3/mTOR, RAS/BRAF, MYC and TP53 reprogram metabolic pathways, allowing cancer cells to overcome unfavorable conditions and enabling them to proliferate at a pathologic rate and metastasize [5,6,7,8,9,10,11].